These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 9649657
1. Production of host-protective (IFN-gamma), host-impairing (IL-10, IL-13) and inflammatory (TNF-alpha) cytokines by PBMC from leprosy patients stimulated with mycobacterial antigens. Machado P, Abrams J, Santos S, Brennan P, Barral A, Barral-Netto M. Eur J Dermatol; 1998 Mar; 8(2):98-103. PubMed ID: 9649657 [Abstract] [Full Text] [Related]
2. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients. Mutis T, Kraakman EM, Cornelisse YE, Haanen JB, Spits H, De Vries RR, Ottenhoff TH. J Immunol; 1993 May 15; 150(10):4641-51. PubMed ID: 8482851 [Abstract] [Full Text] [Related]
4. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery. Sridevi K, Khanna N, Chattree V, Pal PC, Haq W, Rao DN. Int Immunopharmacol; 2003 Nov 15; 3(12):1589-600. PubMed ID: 14555284 [Abstract] [Full Text] [Related]
8. Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contacts. Mathew JM, Muthukkaruppan V. Microb Pathog; 1993 Nov 15; 15(5):367-76. PubMed ID: 8015417 [Abstract] [Full Text] [Related]
9. Recovery of IFN-gamma levels in PBMCs from lepromatous leprosy patients through the synergistic actions of the cytokines IL-12 and IL-18. Lopez Roa RI, Guerrero Velásquez C, Alvarado Navarro A, Montoya Buelna M, Garcia Niebla C, Fafutis Morris M. Int Immunopharmacol; 2008 Dec 20; 8(13-14):1715-20. PubMed ID: 18708162 [Abstract] [Full Text] [Related]
11. IL-6 production in response to purified mycobacterial heat-shock proteins and to antigen 85 in leprosy. Launois P, Vandenbussche P, M'Bayame NN, Drowart A, Van Vooren JP, Sarthou JL, Millan J, Huygen K. Cell Immunol; 1993 May 20; 148(2):283-90. PubMed ID: 8495494 [Abstract] [Full Text] [Related]
15. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS. Int J Lepr Other Mycobact Dis; 1996 Sep 15; 64(3):257-67. PubMed ID: 8862259 [Abstract] [Full Text] [Related]
18. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction. Moura DF, Teles RM, Ribeiro-Carvalho MM, Teles RB, Santos IM, Ferreira H, Fulco TO, Nery JA, Sampaio EP, Sarno EN. Br J Dermatol; 2007 Aug 15; 157(2):273-83. PubMed ID: 17553031 [Abstract] [Full Text] [Related]
19. Immunologic defects in leprosy patients. II. Interleukin 1, interleukin 2, and interferon production in leprosy patients. Makonkawkeyoon S, Kasinrerk W, Supajatura V, Hirunpetcharat C, Vithayasai V. Int J Lepr Other Mycobact Dis; 1990 Jun 15; 58(2):311-8. PubMed ID: 1695911 [Abstract] [Full Text] [Related]
20. Immunological reactions to mycobacterial proteins in the spectrum of leprosy. Rada EM, Aranzazu N, Convit J. Int J Lepr Other Mycobact Dis; 1997 Dec 15; 65(4):497-500. PubMed ID: 9465162 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]